<bill session="112" type="h" number="1988" updated="2019-11-15T21:21:16Z">
  <state datetime="2011-05-25">REFERRED</state>
  <status>
    <introduced datetime="2011-05-25"/>
  </status>
  <introduced datetime="2011-05-25"/>
  <titles>
    <title type="short" as="introduced">Qualifying Therapeutic Discovery Project Tax Credit Extension Act of 2011</title>
    <title type="display">Qualifying Therapeutic Discovery Project Tax Credit Extension Act of 2011</title>
    <title type="official" as="introduced">To amend the Internal Revenue Code of 1986 to extend the qualifying therapeutic discovery project credit.</title>
  </titles>
  <sponsor bioguide_id="D000598"/>
  <cosponsors>
    <cosponsor bioguide_id="B001227" joined="2012-01-25"/>
    <cosponsor bioguide_id="C001072" joined="2012-01-25"/>
    <cosponsor bioguide_id="C001084" joined="2011-11-18"/>
    <cosponsor bioguide_id="C001078" joined="2012-01-25"/>
    <cosponsor bioguide_id="C001069" joined="2012-01-25"/>
    <cosponsor bioguide_id="C001081" joined="2012-01-25"/>
    <cosponsor bioguide_id="F000043" joined="2012-01-25"/>
    <cosponsor bioguide_id="H000324" joined="2012-01-25"/>
    <cosponsor bioguide_id="H001032" joined="2012-01-25"/>
    <cosponsor bioguide_id="K000009" joined="2012-01-25"/>
    <cosponsor bioguide_id="K000375" joined="2012-01-25"/>
    <cosponsor bioguide_id="K000188" joined="2012-01-25"/>
    <cosponsor bioguide_id="M000309" joined="2012-01-25"/>
    <cosponsor bioguide_id="N000015" joined="2011-11-30"/>
    <cosponsor bioguide_id="P000096" joined="2012-01-25"/>
    <cosponsor bioguide_id="R000053" joined="2012-01-25"/>
    <cosponsor bioguide_id="R000462" joined="2012-01-25"/>
    <cosponsor bioguide_id="S001162" joined="2011-05-25"/>
    <cosponsor bioguide_id="S001165" joined="2012-01-25"/>
    <cosponsor bioguide_id="V000128" joined="2011-11-29"/>
  </cosponsors>
  <actions>
    <action datetime="2011-05-25">
      <text>Introduced in House</text>
    </action>
    <action datetime="2011-05-25" state="REFERRED">
      <text>Referred to the Committee on Ways and Means, and in addition to the Committees on Appropriations, and Energy and Commerce, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.</text>
    </action>
    <action datetime="2011-05-25">
      <text>Referred to the Committee on Ways and Means, and in addition to the Committees on Appropriations, and Energy and Commerce, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.</text>
    </action>
    <action datetime="2011-05-25">
      <text>Referred to the Committee on Ways and Means, and in addition to the Committees on Appropriations, and Energy and Commerce, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.</text>
    </action>
    <action datetime="2011-06-03">
      <text>Referred to the Subcommittee on Health.</text>
    </action>
  </actions>
  <committees>
    <committee code="HSIF" name="House Energy and Commerce" subcommittee="" activity="Referral"/>
    <committee code="HSIF14" name="House Energy and Commerce" subcommittee="Health" activity="Referral"/>
    <committee code="HSAP" name="House Appropriations" subcommittee="" activity="Referral"/>
    <committee code="HSWM" name="House Ways and Means" subcommittee="" activity="Referral"/>
  </committees>
  <relatedbills/>
  <subjects>
    <term name="Taxation"/>
    <term name="Business investment and capital"/>
    <term name="Drug therapy"/>
    <term name="Health technology, devices, supplies"/>
    <term name="Income tax credits"/>
    <term name="Medical research"/>
    <term name="Medical tests and diagnostic methods"/>
  </subjects>
  <amendments/>
  <summary date="2011-07-22T18:15:13Z" status="Introduced in House">Qualifying Therapeutic Discovery Project Tax Credit Extension Act of 2011 - Amends the Internal Revenue Code to extend for an additional five-year period the authority to invest in and allocate credit amounts for a qualifying therapeutic discovery project (a project that is designed to: (1) treat or prevent diseases by conducting pre-clinical activities, clinical trials, and clinical studies, or by carrying out research projects to approve new drugs or other biologic products; (2) diagnose diseases or conditions to determine molecular factors related to diseases or conditions; or (3) develop a product, process, or technology to further the delivery or administration of therapeutics).

Extends for an additional five-year period the authority of the Secretary of the Treasury to award grants for investment in a qualifying therapeutic discovery project in lieu of a tax credit and the funding for such grants.</summary>
</bill>
